Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Sanofi to acquire US biotech Dynavax for $2.2 billion
03:08am, Wednesday, 24'th Dec 2025
French drugmaker Sanofi has entered into an agreement to acquire U.S. vaccines company Dynavax Technologies Corporation for around $2.2 billion (1.87 billion euros), it said on Wednesday.
Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal
01:49am, Wednesday, 24'th Dec 2025
The cash deal seeks to strengthen the French drugmaker's immunization portfolio after it suffered setbacks in clinical trials.
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
01:23am, Wednesday, 24'th Dec 2025
Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price on December 23, 2025 EMERYVILLE, Calif. , Dec. 24, 2025 /PRNewswire/ -- Sanofi announced today that it has
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
01:15am, Wednesday, 24'th Dec 2025
Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an agr
Dynavax Technologies (NASDAQ:DVAX) vs. Amgen (NASDAQ:AMGN) Head to Head Survey
01:42am, Friday, 19'th Dec 2025
Amgen (NASDAQ: AMGN - Get Free Report) and Dynavax Technologies (NASDAQ: DVAX - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based o
Geode Capital Management LLC Sells 377,048 Shares of Dynavax Technologies Corporation $DVAX
03:58am, Saturday, 29'th Nov 2025
Geode Capital Management LLC lowered its holdings in Dynavax Technologies Corporation (NASDAQ: DVAX) by 12.3% in the undefined quarter, according to the company in its most recent 13F filing with the
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives $24.33 Average Price Target from Analysts
03:29am, Tuesday, 25'th Nov 2025
Shares of Dynavax Technologies Corporation (NASDAQ: DVAX - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com report
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
04:01pm, Wednesday, 19'th Nov 2025
EMERYVILLE, Calif. , Nov. 19, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, tod
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX
04:43am, Monday, 17'th Nov 2025
Campbell and CO Investment Adviser LLC trimmed its holdings in Dynavax Technologies Corporation (NASDAQ: DVAX) by 38.2% in the second quarter, according to its most recent disclosure with the Securiti
Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript
10:31pm, Wednesday, 05'th Nov 2025
Dynavax Technologies Corporation ( DVAX ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Paul Cox - VP of Investor Relations & Corporate Communications Ryan Spencer - CEO & Di
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
06:20pm, Wednesday, 05'th Nov 2025
Dynavax Technologies (DVAX) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago.
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
04:01pm, Wednesday, 05'th Nov 2025
HEPLISAV-B® quarterly net product revenue of $90 million, a 13% YoY increase; r eiterates full year 2025 HEPLISAV-B® net product revenue guidance range of $315 to $325 million Board of Directors aut
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
04:00pm, Wednesday, 05'th Nov 2025
Collaboration positioned to leverage Vaxart's oral vaccine platform and Dynavax's commercial experience to address the long-term need for easily administered COVID-19 vaccine options Vaxart to continu
139,227 Shares in Dynavax Technologies Corporation $DVAX Purchased by Y Intercept Hong Kong Ltd
03:41am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd bought a new position in Dynavax Technologies Corporation (NASDAQ: DVAX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The i
Dynavax Technologies Corporation $DVAX Shares Sold by Yousif Capital Management LLC
03:48am, Friday, 24'th Oct 2025
Yousif Capital Management LLC trimmed its holdings in Dynavax Technologies Corporation (NASDAQ: DVAX) by 8.2% in the undefined quarter, according to its most recent disclosure with the SEC. The firm o
